Literature DB >> 26626314

SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases.

Karine Choquet1,2, Martine Tétreault2,3, Sharon Yang1, Roberta La Piana1, Marie-Josée Dicaire1, Megan R Vanstone4, Jean Mathieu5, Jean-Pierre Bouchard6, Marie-France Rioux7, Guy A Rouleau8, Kym M Boycott4, Jacek Majewski2,3, Bernard Brais1,2.   

Abstract

Hereditary cerebellar ataxias and hereditary spastic paraplegias are clinically and genetically heterogeneous and often overlapping neurological disorders. Mutations in SPG7 cause the autosomal recessive spastic paraplegia type 7 (SPG7), but recent studies indicate that they are also one of the most common causes of recessive cerebellar ataxia. In Quebec, a significant number of patients affected with cerebellar ataxia and spasticity remain without a molecular diagnosis. We performed whole-exome sequencing in three French Canadian (FC) patients affected with spastic ataxia and uncovered compound heterozygous variants in SPG7 in all three. Sanger sequencing of SPG7 exons and exon/intron boundaries was used to screen additional patients. In total, we identified recessive variants in SPG7 in 22 FC patients belonging to 12 families (38.7% of the families screened), including two novel variants. The p.(Ala510Val) variant was the most common in our cohort. Cerebellar features, including ataxia, were more pronounced than spasticity in this cohort. These results strongly suggest that variants affecting the function of SPG7 are the fourth most common form of recessive ataxia in FC patients. Thus, we propose that SPG7 mutations explain a significant proportion of FC spastic ataxia cases and that this gene should be considered in unresolved patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26626314      PMCID: PMC5070891          DOI: 10.1038/ejhg.2015.240

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

1.  Early-onset optic neuropathy as initial clinical presentation in SPG7.

Authors:  Christian Marcotulli; Luca Leonardi; Alessandra Tessa; Anna Maria De Negris; Riccardo Cornia; Alberto Pierallini; Shalom Haggiag; Francesco Pierelli; Filippo M Santorelli; Carlo Casali
Journal:  J Neurol       Date:  2014-07-18       Impact factor: 4.849

2.  EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.

Authors:  B P C van de Warrenburg; J van Gaalen; S Boesch; J-M Burgunder; A Dürr; P Giunti; T Klockgether; C Mariotti; M Pandolfo; O Riess
Journal:  Eur J Neurol       Date:  2014-01-13       Impact factor: 6.089

3.  Diversity of ARSACS mutations in French-Canadians.

Authors:  I Thiffault; M J Dicaire; M Tetreault; K N Huang; J Demers-Lamarche; G Bernard; A Duquette; R Larivière; K Gehring; A Montpetit; P S McPherson; A Richter; L Montermini; J Mercier; G A Mitchell; N Dupré; C Prévost; J P Bouchard; J Mathieu; B Brais
Journal:  Can J Neurol Sci       Date:  2013-01       Impact factor: 2.104

4.  Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.

Authors:  Stephan Klebe; Christel Depienne; Sylvie Gerber; Georges Challe; Mathieu Anheim; Perrine Charles; Estelle Fedirko; Elodie Lejeune; Julien Cottineau; Alfredo Brusco; Hélène Dollfus; Patrick F Chinnery; Cecilia Mancini; Xavier Ferrer; Guilhem Sole; Alain Destée; Jean-Michel Mayer; Bertrand Fontaine; Jérôme de Seze; Michel Clanet; Elisabeth Ollagnon; Philippe Busson; Cécile Cazeneuve; Giovanni Stevanin; Josseline Kaplan; Jean-Michel Rozet; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

5.  Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany.

Authors:  Daniele Orsucci; Loredana Petrucci; Elena Caldarazzo Ienco; Lucia Chico; Paolo Simi; Antonella Fogli; Fulvia Baldinotti; Costanza Simoncini; Annalisa LoGerfo; Cecilia Carlesi; Alessia Arnoldi; Maria Teresa Bassi; Gabriele Siciliano; Ubaldo Bonuccelli; Michelangelo Mancuso
Journal:  Clin Neurol Neurosurg       Date:  2014-02-17       Impact factor: 1.876

6.  A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia.

Authors:  Philip A Wilkinson; Andrew H Crosby; Christopher Turner; Lloyd J Bradley; Lionel Ginsberg; Nicholas W Wood; Anthony H Schapira; Thomas T Warner
Journal:  Brain       Date:  2004-02-25       Impact factor: 13.501

7.  The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy.

Authors:  Loretta Racis; Alessandra Tessa; Roberto Di Fabio; Eugenia Storti; Virgilio Agnetti; Carlo Casali; Filippo M Santorelli; Maura Pugliatti
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

8.  Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.

Authors:  Gerald Pfeffer; Gráinne S Gorman; Helen Griffin; Marzena Kurzawa-Akanbi; Emma L Blakely; Ian Wilson; Kamil Sitarz; David Moore; Julie L Murphy; Charlotte L Alston; Angela Pyle; Jon Coxhead; Brendan Payne; George H Gorrie; Cheryl Longman; Marios Hadjivassiliou; John McConville; David Dick; Ibrahim Imam; David Hilton; Fiona Norwood; Mark R Baker; Stephan R Jaiser; Patrick Yu-Wai-Man; Michael Farrell; Allan McCarthy; Timothy Lynch; Robert McFarland; Andrew M Schaefer; Douglass M Turnbull; Rita Horvath; Robert W Taylor; Patrick F Chinnery
Journal:  Brain       Date:  2014-04-10       Impact factor: 13.501

9.  Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.

Authors:  G Casari; M De Fusco; S Ciarmatori; M Zeviani; M Mora; P Fernandez; G De Michele; A Filla; S Cocozza; R Marconi; A Dürr; B Fontaine; A Ballabio
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

10.  SPG7 mutations are a common cause of undiagnosed ataxia.

Authors:  Gerald Pfeffer; Angela Pyle; Helen Griffin; Jack Miller; Valerie Wilson; Lisa Turnbull; Katherine Fawcett; David Sims; Gail Eglon; Marios Hadjivassiliou; Rita Horvath; Andrea Németh; Patrick F Chinnery
Journal:  Neurology       Date:  2015-02-13       Impact factor: 11.800

View more
  15 in total

Review 1.  Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways.

Authors:  Matthis Synofzik; Rebecca Schüle
Journal:  Mov Disord       Date:  2017-02-14       Impact factor: 10.338

2.  Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7.

Authors:  Giulia Coarelli; Rebecca Schule; Bart P C van de Warrenburg; Peter De Jonghe; Claire Ewenczyk; Andrea Martinuzzi; Matthis Synofzik; Elisa G Hamer; Jonathan Baets; Mathieu Anheim; Ludger Schöls; Tine Deconinck; Pegah Masrori; Bertrand Fontaine; Thomas Klockgether; Maria Grazia D'Angelo; Marie-Lorraine Monin; Jan De Bleecker; Isabelle Migeotte; Perrine Charles; Maria Teresa Bassi; Thomas Klopstock; Fanny Mochel; Elisabeth Ollagnon-Roman; Marc D'Hooghe; Christoph Kamm; Delia Kurzwelly; Melanie Papin; Claire-Sophie Davoine; Guillaume Banneau; Sophie Tezenas du Montcel; Danielle Seilhean; Alexis Brice; Charles Duyckaerts; Giovanni Stevanin; Alexandra Durr
Journal:  Neurology       Date:  2019-05-08       Impact factor: 9.910

3.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

4.  Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypes.

Authors:  Miao Sun; Amy Knight Johnson; Viswateja Nelakuditi; Lucia Guidugli; David Fischer; Kelly Arndt; Lan Ma; Erin Sandford; Vikram Shakkottai; Kym Boycott; Jodi Warman-Chardon; Zejuan Li; Daniela Del Gaudio; Margit Burmeister; Christopher M Gomez; Darrel J Waggoner; Soma Das
Journal:  Genet Med       Date:  2018-06-18       Impact factor: 8.822

5.  Loss of the Drosophila m-AAA mitochondrial protease paraplegin results in mitochondrial dysfunction, shortened lifespan, and neuronal and muscular degeneration.

Authors:  Gautam Pareek; Ruth E Thomas; Leo J Pallanck
Journal:  Cell Death Dis       Date:  2018-02-21       Impact factor: 8.469

6.  Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China.

Authors:  En-Lin Dong; Chong Wang; Shuang Wu; Ying-Qian Lu; Xiao-Hong Lin; Hui-Zhen Su; Miao Zhao; Jin He; Li-Xiang Ma; Ning Wang; Wan-Jin Chen; Xiang Lin
Journal:  Mol Neurodegener       Date:  2018-07-06       Impact factor: 14.195

7.  Novel genotype-phenotype and MRI correlations in a large cohort of patients with SPG7 mutations.

Authors:  Channa A Hewamadduma; Nigel Hoggard; Ronan O'Malley; Megan K Robinson; Nick J Beauchamp; Ruta Segamogaite; Jo Martindale; Tobias Rodgers; Ganesh Rao; Ptolemaios Sarrigiannis; Priya Shanmugarajah; Panagiotis Zis; Basil Sharrack; Christopher J McDermott; Pamela J Shaw; Marios Hadjivassiliou
Journal:  Neurol Genet       Date:  2018-10-24

8.  A deep intronic splice variant advises reexamination of presumably dominant SPG7 Cases.

Authors:  Edgard Verdura; Agatha Schlüter; Gorka Fernández-Eulate; Raquel Ramos-Martín; Miren Zulaica; Laura Planas-Serra; Montserrat Ruiz; Stéphane Fourcade; Carlos Casasnovas; Adolfo López de Munain; Aurora Pujol
Journal:  Ann Clin Transl Neurol       Date:  2019-12-18       Impact factor: 4.511

Review 9.  Childhood-onset hereditary spastic paraplegia and its treatable mimics.

Authors:  Darius Ebrahimi-Fakhari; Afshin Saffari; Phillip L Pearl
Journal:  Mol Genet Metab       Date:  2021-06-24       Impact factor: 4.797

10.  Genetic and phenotypic characterization of complex hereditary spastic paraplegia.

Authors:  Eleanna Kara; Arianna Tucci; Claudia Manzoni; David S Lynch; Marilena Elpidorou; Conceicao Bettencourt; Viorica Chelban; Andreea Manole; Sherifa A Hamed; Nourelhoda A Haridy; Monica Federoff; Elisavet Preza; Deborah Hughes; Alan Pittman; Zane Jaunmuktane; Sebastian Brandner; Georgia Xiromerisiou; Sarah Wiethoff; Lucia Schottlaender; Christos Proukakis; Huw Morris; Tom Warner; Kailash P Bhatia; L V Prasad Korlipara; Andrew B Singleton; John Hardy; Nicholas W Wood; Patrick A Lewis; Henry Houlden
Journal:  Brain       Date:  2016-05-23       Impact factor: 15.255

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.